Natco Pharma launches breast cancer drug in US

Natco Pharma on Tuesday said it has launched a generic version of anastrazole, used in treating breast cancer, in the US market.The company has launched the drug in strength of 1 mg tablets in the US after getting US Food and Drugs Administration’s nod, Natco Pharma said in a statement.The product has been launched in the US through the company’s marketing partners; it said but did not name the associates.................&  more

No comments:

Post a Comment